We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Innovative Device Reconstructs Gastroesophageal Reflux Barrier

By HospiMedica International staff writers
Posted on 02 Jan 2018
Print article
Image: The EsophyX Z+ device with close up of tissue mold (Photo courtesy of EndoGastric Solutions).
Image: The EsophyX Z+ device with close up of tissue mold (Photo courtesy of EndoGastric Solutions).
A novel transoral endoscopic system enables physicians to rebuild the gastroesophageal valve (GEV) with a partial fundoplication technique.

The EndoGastric Solutions (Redmond, WA, USA) EsophyX Z+ device offers patients who need to undergo an anatomical repair of the GEV an effective treatment option to correct severe gastroesophageal reflux disease (GERD). The device enables the creation of a 2-3 cm, 270° esophagogastric fundoplication, using the transoral incisionless fundoplication (TIF) technique. A flexible video endoscope is first inserted into the central lumen of the EsophyX device to provide direct visualization throughout the TIF procedure.

A helical retractor is then used to retract tissue and anchor the gastroesophageal junction during the fundoplication. It then stows away safely inside the tissue mold during insertion and removal. The next stage involves the Tissue Mold and Chassis, which plicates and compresses the tissue and rotates the fundus around esophagus to create a partial wrap. An Invaginator then suctions the tissue to reduce the small hiatal hernia, facilitating positioning of the fundoplication caudal to the diaphragm. Finally, stylets and SerosaFuse fasteners are used to transect the apposed tissues and maintain tissue compression throughout the healing process.

“We are excited to launch the EsophyX Z+ device, as we believe it will further enhance the physician’s technical experience,” said Skip Baldino, President and CEO of EndoGastric Solutions. “At EndoGastric Solutions, we are committed to addressing the unmet needs in gastrointestinal diseases and offering physicians highly effective options that fill the significant treatment gap between medication and more invasive surgery.”

“GERD is a chronic condition, and proton pump inhibitors do not control symptoms in about one-third of patients,” said surgeon Michael Murray, MD, of Northern Nevada Medical Center (Sparks, NV, USA). “The design of the new EsophyX Z+ device makes performing TIF 2.0 procedures technically easy, and produces a consistent and effective fundoplication, providing an effective alternative to prescription medications and traditional surgical procedures.”

GERD is a chronic condition in which the GEV allows gastric contents to reflux into the esophagus, causing heartburn and possible injury to the esophageal lining. In most GERD patients, the esophageal sphincter is weakened and does not close tightly, allowing digestive juices to return and irritate the esophageal lining. Fundoplication, which involves folding and reinforcing the annulus between the esophagus and the stomach by wrapping the upper portion of the stomach around the lowest portion of the esophagus, can help restore the compromised reflux barrier.

Related Links:
EndoGastric Solutions

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Vital Signs Monitor
Aurus 10

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.